(1)
Monteiro, I.; Cordeiro, F.; Martins, T.; Medeiros, C. PE-041 Impact Associated With Pertuzumab and Trastuzumab SC and IV Formulations Utilization in Metastatic HER2- Positive Breast Cancer Patients Treated in SUS. JAFF 2025, 9.